BioGaia AB (publ) (STO:BIOG.B)
Sweden
· Delayed Price · Currency is SEK 109.60
-0.70 (-0.63%)
At close: Mar 9, 2026
BioGaia AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,538 | 1,423 | 1,297 | 1,104 | 785.11 | Upgrade
|
| Revenue Growth (YoY) | 8.12% | 9.74% | 17.44% | 40.61% | 5.09% | Upgrade
|
| Cost of Revenue | 409.59 | 391.98 | 346.32 | 302.03 | 202.16 | Upgrade
|
| Gross Profit | 1,129 | 1,031 | 950.19 | 801.93 | 582.95 | Upgrade
|
| Selling, General & Admin | 560.89 | 464.28 | 402.51 | 360.62 | 230.76 | Upgrade
|
| Research & Development | 115.72 | 105.95 | 106.78 | 106.81 | 105.47 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 0 | Upgrade
|
| Operating Expenses | 676.61 | 570.23 | 509.28 | 467.42 | 336.23 | Upgrade
|
| Operating Income | 451.97 | 460.51 | 440.91 | 334.51 | 246.72 | Upgrade
|
| Interest Expense | -6.06 | -1.44 | -0.81 | -5.39 | -1.13 | Upgrade
|
| Interest & Investment Income | 17.2 | 39.37 | 41.53 | 7.96 | 0.11 | Upgrade
|
| Currency Exchange Gain (Loss) | -39.51 | 13.89 | 1.82 | 26.79 | 11.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | - | 3.56 | - | Upgrade
|
| EBT Excluding Unusual Items | 423.61 | 512.33 | 483.45 | 367.44 | 256.84 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -4.23 | Upgrade
|
| Impairment of Goodwill | - | -5.3 | - | - | - | Upgrade
|
| Asset Writedown | - | -45.85 | - | - | - | Upgrade
|
| Other Unusual Items | -2.39 | -13.37 | -14.62 | 80.17 | 0.1 | Upgrade
|
| Pretax Income | 421.22 | 447.82 | 468.83 | 447.61 | 252.71 | Upgrade
|
| Income Tax Expense | 88.46 | 96.43 | 103.48 | 73.84 | 56.44 | Upgrade
|
| Earnings From Continuing Operations | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 | Upgrade
|
| Net Income to Company | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 | Upgrade
|
| Net Income | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 | Upgrade
|
| Net Income to Common | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 | Upgrade
|
| Net Income Growth | -5.30% | -3.82% | -2.25% | 90.44% | 9.20% | Upgrade
|
| Shares Outstanding (Basic) | 101 | 101 | 101 | 101 | 101 | Upgrade
|
| Shares Outstanding (Diluted) | 101 | 101 | 101 | 101 | 101 | Upgrade
|
| Shares Change (YoY) | 0.09% | 0.09% | - | - | 13.11% | Upgrade
|
| EPS (Basic) | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 | Upgrade
|
| EPS (Diluted) | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 | Upgrade
|
| EPS Growth | -5.38% | -3.91% | -2.22% | 90.72% | -3.64% | Upgrade
|
| Free Cash Flow | 303.04 | 359.46 | 377.4 | 301.03 | 215.5 | Upgrade
|
| Free Cash Flow Per Share | 3.00 | 3.56 | 3.74 | 2.98 | 2.13 | Upgrade
|
| Dividend Per Share | 1.640 | 1.950 | 1.900 | 1.450 | 0.730 | Upgrade
|
| Dividend Growth | -15.90% | 2.63% | 31.03% | 98.63% | 7.04% | Upgrade
|
| Gross Margin | 73.37% | 72.45% | 73.29% | 72.64% | 74.25% | Upgrade
|
| Operating Margin | 29.38% | 32.37% | 34.01% | 30.30% | 31.42% | Upgrade
|
| Profit Margin | 21.63% | 24.70% | 28.18% | 33.86% | 25.00% | Upgrade
|
| Free Cash Flow Margin | 19.70% | 25.27% | 29.11% | 27.27% | 27.45% | Upgrade
|
| EBITDA | 476.64 | 477.17 | 455.44 | 348.71 | 259.98 | Upgrade
|
| EBITDA Margin | 30.99% | 33.54% | 35.13% | 31.59% | 33.11% | Upgrade
|
| D&A For EBITDA | 24.67 | 16.66 | 14.53 | 14.2 | 13.25 | Upgrade
|
| EBIT | 451.97 | 460.51 | 440.91 | 334.51 | 246.72 | Upgrade
|
| EBIT Margin | 29.38% | 32.37% | 34.01% | 30.30% | 31.42% | Upgrade
|
| Effective Tax Rate | 21.00% | 21.53% | 22.07% | 16.50% | 22.33% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.